James A. Troy, MD, MHS
Triple therapy reduces exacerbations in patients with symptomatic COPD
September 4, 2017
Does triple therapy (long-acting beta2-agonist, long-acting muscarinic antagonist, and inhaled corticosteroid) reduce exacerbations in patients with symptomatic COPD?
HEART score can safely identify low risk chest pain
September 2, 2017
Clinical Question: Can the HEART score risk stratify emergency department patients with chest pain?